These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Phenotypic screening strategies for neurodegenerative diseases: a pathway to discover novel drug candidates and potential disease targets or mechanisms. Pruss RM CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):693-700. PubMed ID: 20942792 [TBL] [Abstract][Full Text] [Related]
6. Safety screening in early drug discovery: An optimized assay panel. Bendels S; Bissantz C; Fasching B; Gerebtzoff G; Guba W; Kansy M; Migeon J; Mohr S; Peters JU; Tillier F; Wyler R; Lerner C; Kramer C; Richter H; Roberts S J Pharmacol Toxicol Methods; 2019; 99():106609. PubMed ID: 31284073 [TBL] [Abstract][Full Text] [Related]
7. The insulin secretory action of novel polycyclic guanidines: discovery through open innovation phenotypic screening, and exploration of structure-activity relationships. Shaghafi MB; Barrett DG; Willard FS; Overman LE Bioorg Med Chem Lett; 2014 Feb; 24(4):1031-6. PubMed ID: 24484900 [TBL] [Abstract][Full Text] [Related]
8. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362 [TBL] [Abstract][Full Text] [Related]
9. Single cell network profiling (SCNP): mapping drug and target interactions. Covey TM; Putta S; Cesano A Assay Drug Dev Technol; 2010 Jun; 8(3):321-43. PubMed ID: 20158439 [TBL] [Abstract][Full Text] [Related]
10. Systematic Identification of Pharmacological Targets from Small-Molecule Phenotypic Screens. Liu X; Baarsma HA; Thiam CH; Montrone C; Brauner B; Fobo G; Heier JS; Duscha S; Königshoff M; Angeli V; Ruepp A; Campillos M Cell Chem Biol; 2016 Oct; 23(10):1302-1313. PubMed ID: 27667560 [TBL] [Abstract][Full Text] [Related]
11. High-throughput biochemical kinase selectivity assays: panel development and screening applications. Card A; Caldwell C; Min H; Lokchander B; Hualin Xi ; Sciabola S; Kamath AV; Clugston SL; Tschantz WR; Leyu Wang ; Moshinsky DJ J Biomol Screen; 2009 Jan; 14(1):31-42. PubMed ID: 19073965 [TBL] [Abstract][Full Text] [Related]
12. Using Thermogenic Beige Cells to Identify Biologically Active Small Molecules and Peptides. Wu L; Xu B Methods Mol Biol; 2017; 1566():203-212. PubMed ID: 28244053 [TBL] [Abstract][Full Text] [Related]
13. A novel approach applying a chemical biology strategy in phenotypic screening reveals pathway-selective regulators of histone 3 K27 tri-methylation. Liu Y; Platchek M; Kement B; Bee WT; Truong M; Zeng X; Hung S; Lin H; Morrow D; Kallal LA; Xie Q; Agarwal P; Pope AJ; Wu Z Mol Biosyst; 2014 Feb; 10(2):251-7. PubMed ID: 24257700 [TBL] [Abstract][Full Text] [Related]
14. A Screening Assay Cascade to Identify and Characterize Novel Selective Estrogen Receptor Downregulators (SERDs). Callis R; Rabow A; Tonge M; Bradbury R; Challinor M; Roberts K; Jones K; Walker G J Biomol Screen; 2015 Jul; 20(6):748-59. PubMed ID: 25851036 [TBL] [Abstract][Full Text] [Related]
15. Quantitative Prioritization of Tool Compounds for Phenotypic Screening. Wang Y; Jenkins JL Methods Mol Biol; 2018; 1787():195-206. PubMed ID: 29736720 [TBL] [Abstract][Full Text] [Related]
16. Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches. Lee JA; Berg EL J Biomol Screen; 2013 Dec; 18(10):1143-55. PubMed ID: 24080259 [TBL] [Abstract][Full Text] [Related]
17. A simple statistical test to infer the causality of target/phenotype correlation from small molecule phenotypic screens. Wei X; Hoffman AF; Hamilton SM; Xiang Q; He Y; So WV; So SS; Mark D Bioinformatics; 2012 Feb; 28(3):301-5. PubMed ID: 22155864 [TBL] [Abstract][Full Text] [Related]
18. Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasion. Gallardo VE; Varshney GK; Lee M; Bupp S; Xu L; Shinn P; Crawford NP; Inglese J; Burgess SM Dis Model Mech; 2015 Jun; 8(6):565-76. PubMed ID: 25810455 [TBL] [Abstract][Full Text] [Related]
19. Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery. Okombo J; Chibale K Acc Chem Res; 2017 Jul; 50(7):1606-1616. PubMed ID: 28636311 [TBL] [Abstract][Full Text] [Related]
20. Building predictive models for mechanism-of-action classification from phenotypic assay data sets. Berg EL; Yang J; Polokoff MA J Biomol Screen; 2013 Dec; 18(10):1260-9. PubMed ID: 24088371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]